Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Insider Sells 20,000 Shares of Stock

Key Points

• Liquidia Technologies insider Rajeev Saggar sold 20,000 shares at an average price of $27.85, totaling $557,000, which reduced his ownership by 7.41% to 249,727 shares.
• The company's stock performance shows a current trading price of $28.58 with a year-to-date range between a 52-week low of $8.75 and a high of $29.28.
• Liquidia Technologies reported a revenue increase of 141.5% year-over-year, totaling $8.84 million, although it missed the consensus EPS estimates.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 20,000 shares of the firm's stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of $27.85, for a total value of $557,000.00. Following the completion of the transaction, the insider directly owned 249,727 shares in the company, valued at $6,954,896.95. This trade represents a 7.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Rajeev Saggar also recently made the following trade(s):

• On Thursday, August 28th, Rajeev Saggar sold 20,000 shares of Liquidia Technologies stock. The stock was sold at an average price of $27.85, for a total value of $557,000.00.
• On Monday, July 21st, Rajeev Saggar sold 2,526 shares of Liquidia Technologies stock. The stock was sold at an average price of $14.54, for a total value of $36,728.04.
• On Monday, July 14th, Rajeev Saggar sold 5,327 shares of Liquidia Technologies stock. The stock was sold at an average price of $14.28, for a total value of $76,069.56.

Liquidia Technologies Price Performance

Shares of NASDAQ LQDA traded up $0.90 during mid-day trading on Tuesday, reaching $28.58. The company's stock had a trading volume of 3,973,236 shares, compared to its average volume of 1,817,921. The firm has a market capitalization of $2.46 billion, a PE ratio of -16.81 and a beta of 0.22. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The stock has a fifty day moving average of $19.18 and a two-hundred day moving average of $16.44. Liquidia Technologies, Inc. has a 52 week low of $8.75 and a 52 week high of $29.28.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The firm had revenue of $8.84 million for the quarter, compared to the consensus estimate of $3.90 million. Liquidia Technologies's revenue was up 141.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Hedge Funds Weigh In On Liquidia Technologies

Hedge funds have recently added to or reduced their stakes in the company. NewEdge Advisors LLC bought a new position in Liquidia Technologies during the 2nd quarter valued at about $25,000. Hurley Capital LLC bought a new position in Liquidia Technologies during the 1st quarter valued at about $32,000. GAMMA Investing LLC grew its holdings in Liquidia Technologies by 65.6% during the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in Liquidia Technologies by 24.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock valued at $77,000 after buying an additional 1,200 shares in the last quarter. Finally, Quarry LP bought a new stake in Liquidia Technologies during the 1st quarter valued at about $79,000. 64.54% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. BTIG Research reissued a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Scotiabank increased their price target on shares of Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Wells Fargo & Company increased their price target on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a report on Wednesday, August 13th. Jefferies Financial Group started coverage on shares of Liquidia Technologies in a report on Friday, August 15th. They issued a "buy" rating and a $43.00 price target for the company. Finally, Raymond James Financial increased their price target on shares of Liquidia Technologies from $33.00 to $41.00 and gave the company a "strong-buy" rating in a report on Wednesday, August 13th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $32.11.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.